Graves’ ophthalmopathy – thyroid eye disease
Keywords
Thyroid eye disease, Graves’ ophthalmopathy, Graves’ orbitopathyAbstract
Graves’ disease (GD) is an autoimmune disorder that affects thyroid. It is caused by antibody, named thyroid-stimulating immunoglobulin (TIS) that acts like thyroid stimulating hormone (TSH), resulting in thyroid hormone overproduction – condition called hyperthyroidism. TSH receptors are located on thyroid cells, but also on ocular fibroblasts – that’s why Graves’ disease can result in ocular manifestations also known as Graves ophthalmopathy (GO). Typically patients with hyperthyroidism are affected by ophthalmopathy, but it can occur in hypothyroid or euthyroid patients as well. It is estimated that 20-35% of patients with Graves' disease develop thyroid eye disease. In most cases symptoms are mild and do not require specialist treatment. Decision about therapy should be made considering severity of the disease and it is influence on quality of life.Downloads
Published
2019-08-17
How to Cite
1.
SIEDLECKA, Dagna, MICAŁ, Wojciech, KRZEWICKA-ROMANIUK, Ewa and NAZZAL, Rashed Mustafa. Graves’ ophthalmopathy – thyroid eye disease. Journal of Education, Health and Sport. Online. 17 August 2019. Vol. 9, no. 8, pp. 795-800. [Accessed 12 December 2024].
Issue
Section
Review Articles
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 347
Number of citations: 0